PARP1 and atrial fibrillation: In conclusion, both pharmacological inhibitors of PARP1 and nutritional supplements of NAD+ (in the form of VitB3) can break the vicious circle caused by oxidative DNA damage in AF and thus represent novel therapeutic options for AF.